Article Per Year (5 Year)
p-Index From 2018 - 2023
0
P-Index
This Author published in this journals
All Journal eJurnal Kedokteran Indonesia Indonesian Journal of Cancer
Tommy Supit
Medical Science Program, Faculty of Medicine Universitas Indonesia
Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Prevalence and Seven-day Observation of Critically Ill Patients in Cipto Mangunkusumo Hospital, Jakarta: A Preliminary Study Tommy Supit; Meliani Anggreni; Riyadh Firdaus
eJournal Kedokteran Indonesia Vol 1, No 3 (2013): Desember
Publisher : Faculty of Medicine Universitas Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Current medical record system in Cipto Mangunkusumo Hospital (RSCM) does not allow up-to-dateidentification for patients with critical condition. As an effort on improving the rapid response of themedical team, this study aims to determine the number of critically ill patients and the incidence ofemergency activation (code blue) during the study period. A longitudinal study was conducted for allinpatients that were critically ill in RSCM ward from 19th to 26th April 2013. Via consecutive sampling,critically ill patients were selected based on the code blue criteria. Selected patients were then observedfor seven days to determine the incidence of cardiopulmonary arrest and their 24-hour survival. Outof 428 patients who were treated in the hospital ward on 19th April 2013, 13 patients (3%) were incritical condition. Primary diagnoses of the critically ill patients varied from infections, auto-immune tomalignancies. Four deaths occurred with three emergency activations; 1 central and 2 regional. Threepercent of all the inpatients treated in the hospital ward were critically ill. Thirty percent of those patientexperienced cardiac arrests. All four arrests resulted in deaths, including two do not resuscitate patients.Data obtained from this study are preliminary and has identified existing problems that requires furtherstudies for confirmation. This study also illuminate the importance of integrated-electrical medicalrecord system.Keywords: prevalence, critically ill, inpatients, Cipto Mangunkusumo Hospital
ABVD versus Stanford V Regimen in Unfavorable Classical Hodgkins Lymphoma TOMMY SUPIT; ZULKIFLI AMIN
Indonesian Journal of Cancer Vol 7, No 4 (2013): Oct - Dec 2013
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v7i4.314

Abstract

Latar belakang: dilaporkan pasien yang terdiagnosis unfavorable limfoma Hodgkin klasik stadium IIB. Pedoman terapi onkologi memasukkan regimen doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) dan Standford V sebagai pilihan pengobatan. Namun, sampai saat ini tidak ada tinjauan sistematis atau analisis-meta yang membandingakan kedua rejimen tersebut yang spesifik untuk kasus ini. Studi kasus ini akan menganalisis hasil uji klinis untuk mengetahui apakah salah satu dari rejimen yang tersebut lebih unggul berdasarkan efikasi klinis dan profil toksisitas.Metodologi: pencarian sistematis dilakukan melalui database EMBASE and Cochrane.Laporan kasus ini menelaah beberapa publikasi dalam bahasa Inggris yang berdasarkan uji klinik acak terkendali.Hasil: tiga hasil uji klinik acak terkendali dengan ketersediaan teks lengkap dievaluasi dalam laporan ini. Dua penelitian telah menunjukkan keunggulan ABVD dibandingkan dengan rejimen Standford V yang dimodifikasi, sementara studi lain menunjukkan keunggulan ABVD yang tidak signifikan. Namun, komponen radioterapi regimen Standford V yang digunakan dalam ketiga penelitian tersebut lebih restriktif dibanding dengan rejimen Standford V yang standar.Kesimpulan: ABVD dan rejimen Standford V merupakan dua pilihan yang dapat digunakan untuk mengobati limfoma Hodgkin klasik.Kata Kunci: limfoma Hodgkin, ABVD, Stanford V, perbandingan, efikasi klinik, toksisitas, NCCN, ESMO
Co-Authors Meliani Anggreni Riyadh Firdaus Zulkifli Amin